<DOC>
	<DOCNO>NCT00654433</DOCNO>
	<brief_summary>Eligible research subject receive unrelated umbilical cord blood transfusion possible cure inherit metabolic disease . A portion cord blood cell ( ALD-101 ) separate cord blood unit give approximately 4 hour standard cord blood transfusion . The study test supplemental cell increase speed normal level circulate blood cell re-established transplant .</brief_summary>
	<brief_title>ALD-101 Adjuvant Therapy Unrelated Umbilical Cord Blood Transfusion ( UCBT ) Patients With Inherited Metabolic Diseases</brief_title>
	<detailed_description>Subjects hospitalize undergo high dos chemotherapy destroy child 's normal cell include bone marrow ( form blood cell ) order prepare body umbilical cord blood transplant . The cord blood transplant intend rescue child 's bone marrow bad effect procedure . The child receive 80 % standard cord blood transplant follow 20 % supplemental stem cell call ALD-101 . The study evaluate cell ( ALD-101 ) repopulate bone marrow rapidly transplant . This would shorten period time transplant subject would risk infection bleed would also decrease number red blood cell platelet transfusion need . ALD-101 use supplement cord blood transplant twenty-eight child genetic disease malignancy one previous clinical study on-going . The main purpose research study test whether portion cord blood cell separate cord blood unit ( ALD-101 ) increase speed normal level circulate blood cell re-established transplant . This experimental part study . ALD-101 also test see safe .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Lysosomal Storage Diseases</mesh_term>
	<criteria>confirm diagnosis inherit metabolic disease ; include follow : Hurler Syndrome ( MPS I ) HurlerScheie Syndrome Hunter Syndrome ( MPS II ) Sanfilippo Syndrome A B ( MPS III ) MaroteauxLamy Syndrome ( MPS VI ) Krabbe Disease ( Globoid Leukodystrophy ) Metachromatic Leukodystrophy ( MLD ) Adrenoleukodystrophy ( ALD AMN ) Sandhoff Disease Tay Sachs Disease Pelizaeus Merzbacher ( PMD ) NiemannPick Disease Alphamannosidosis ICell Disease ( ML II ) Fucosidosis GM I Gangliosidosis Canavan Disease must &lt; 16 year age time study enrollment must good performance status ( Lansky â‰¥80 % ) must adequate function organ system include : kidney , liver , heart lung must give valid write informed consent must minimum life expectancy least 6 month must determine good candidate standard umbilical cord blood transplant must IQ &gt; 70 young IQ test potential reach endpoint age 5 HIV , Hepatitis B and/or Hepatitis C positive concurrently involved clinical study affect engraftment immune reconstitution uncontrolled seizure , apnea , evidence aspiration pneumonia , evidence brain stem involvement uncontrolled infection prior allogeneic stem cell transplant cytoreduction preparative therapy within 12 month enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Hurler Syndrome</keyword>
	<keyword>MPS I</keyword>
	<keyword>Hurler-Scheie Syndrome</keyword>
	<keyword>Hunter Syndrome</keyword>
	<keyword>MPS II</keyword>
	<keyword>Sanfilippo Syndrome</keyword>
	<keyword>MPS III</keyword>
	<keyword>Maroteaux-Lamy Syndrome</keyword>
	<keyword>MPS VI</keyword>
	<keyword>Krabbe Disease</keyword>
	<keyword>Globoid Leukodystrophy</keyword>
	<keyword>Metachromatic Leukodystrophy</keyword>
	<keyword>MLD</keyword>
	<keyword>Adrenoleukodystrophy</keyword>
	<keyword>ALD</keyword>
	<keyword>Adrenomyeloneuropathy</keyword>
	<keyword>AMN</keyword>
	<keyword>Sandhoff Disease</keyword>
	<keyword>Tay Sachs Disease</keyword>
	<keyword>Pelizaeus Merzbacher</keyword>
	<keyword>PMD</keyword>
	<keyword>Niemann-Pick Disease A</keyword>
	<keyword>Niemann-Pick Disease B</keyword>
	<keyword>Alpha-mannosidosis</keyword>
	<keyword>Inherited metabolic disease</keyword>
	<keyword>Inborn error metabolism</keyword>
	<keyword>Lysosomal storage disease</keyword>
	<keyword>Peroxisomal storage disease</keyword>
	<keyword>Hematopoietic stem cell transplantation</keyword>
	<keyword>Umbilical cord blood transplantation</keyword>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>Mucopolysaccharidosis I</keyword>
	<keyword>Mucopolysaccharidosis II</keyword>
	<keyword>Mucopolysaccharidosis III</keyword>
	<keyword>Mucopolysaccharidosis VI</keyword>
	<keyword>I Cell disease</keyword>
	<keyword>Fucosidosis</keyword>
	<keyword>GM1 Gangliosidosis</keyword>
	<keyword>Canavan Disease</keyword>
</DOC>